Contraindicated (one)pentobarbital will decrease the extent or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with strong CYP3A4 inducers can result in reduced serum concentrations and lack of antimalarial efficacy Routine formin